vs
Side-by-side financial comparison of BALCHEM CORP (BCPC) and Innovex International, Inc. (INVX). Click either name above to swap in a different company.
Innovex International, Inc. is the larger business by last-quarter revenue ($273.6M vs $270.7M, roughly 1.0× BALCHEM CORP). BALCHEM CORP runs the higher net margin — 14.9% vs 5.1%, a 9.8% gap on every dollar of revenue. On growth, Innovex International, Inc. posted the faster year-over-year revenue change (9.1% vs 8.1%). Over the past eight quarters, Innovex International, Inc.'s revenue compounded faster (46.2% CAGR vs 7.5%).
Balchem Corp is a global specialty chemicals and nutritional ingredients provider that develops, manufactures and distributes application-specific products for human nutrition, animal health, pharmaceutical and industrial end markets, serving customers across North America, Europe and Asia Pacific.
BCPC vs INVX — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $270.7M | $273.6M |
| Net Profit | $40.3M | $14.0M |
| Gross Margin | — | 28.9% |
| Operating Margin | 20.5% | 9.4% |
| Net Margin | 14.9% | 5.1% |
| Revenue YoY | 8.1% | 9.1% |
| Net Profit YoY | 8.7% | -56.1% |
| EPS (diluted) | $1.25 | $0.20 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $270.7M | — | ||
| Q4 25 | $263.6M | $273.6M | ||
| Q3 25 | $267.6M | $240.0M | ||
| Q2 25 | $255.5M | $224.2M | ||
| Q1 25 | $250.5M | $240.4M | ||
| Q4 24 | $240.0M | $250.7M | ||
| Q3 24 | $239.9M | $151.8M | ||
| Q2 24 | $234.1M | $130.3M |
| Q1 26 | $40.3M | — | ||
| Q4 25 | $39.2M | $14.0M | ||
| Q3 25 | $40.3M | $39.2M | ||
| Q2 25 | $38.3M | $15.3M | ||
| Q1 25 | $37.1M | $14.8M | ||
| Q4 24 | $33.6M | $31.8M | ||
| Q3 24 | $33.8M | $82.6M | ||
| Q2 24 | $32.1M | $9.5M |
| Q1 26 | — | — | ||
| Q4 25 | 35.6% | 28.9% | ||
| Q3 25 | 35.7% | 31.6% | ||
| Q2 25 | 36.4% | 32.0% | ||
| Q1 25 | 35.2% | 31.8% | ||
| Q4 24 | 36.0% | 33.9% | ||
| Q3 24 | 35.6% | 34.7% | ||
| Q2 24 | 35.5% | 35.3% |
| Q1 26 | 20.5% | — | ||
| Q4 25 | 19.8% | 9.4% | ||
| Q3 25 | 20.4% | 26.0% | ||
| Q2 25 | 20.1% | 10.1% | ||
| Q1 25 | 20.4% | 9.1% | ||
| Q4 24 | 19.8% | 10.7% | ||
| Q3 24 | 20.0% | -8.7% | ||
| Q2 24 | 19.6% | 10.0% |
| Q1 26 | 14.9% | — | ||
| Q4 25 | 14.9% | 5.1% | ||
| Q3 25 | 15.1% | 16.3% | ||
| Q2 25 | 15.0% | 6.8% | ||
| Q1 25 | 14.8% | 6.1% | ||
| Q4 24 | 14.0% | 12.7% | ||
| Q3 24 | 14.1% | 54.4% | ||
| Q2 24 | 13.7% | 7.3% |
| Q1 26 | $1.25 | — | ||
| Q4 25 | $1.21 | $0.20 | ||
| Q3 25 | $1.24 | $0.57 | ||
| Q2 25 | $1.17 | $0.22 | ||
| Q1 25 | $1.13 | $0.21 | ||
| Q4 24 | $1.03 | $-0.03 | ||
| Q3 24 | $1.03 | $1.99 | ||
| Q2 24 | $0.98 | $0.30 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $72.9M | — |
| Total DebtLower is stronger | — | $18.9M |
| Stockholders' EquityBook value | $1.3B | $1.1B |
| Total Assets | $1.7B | $1.3B |
| Debt / EquityLower = less leverage | — | 0.02× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $72.9M | — | ||
| Q4 25 | $74.6M | — | ||
| Q3 25 | $65.1M | — | ||
| Q2 25 | $65.4M | — | ||
| Q1 25 | $49.9M | — | ||
| Q4 24 | $49.5M | — | ||
| Q3 24 | $73.7M | — | ||
| Q2 24 | $63.7M | $185.6M |
| Q1 26 | — | — | ||
| Q4 25 | — | $18.9M | ||
| Q3 25 | — | $20.1M | ||
| Q2 25 | — | $34.8M | ||
| Q1 25 | — | $19.7M | ||
| Q4 24 | — | $24.9M | ||
| Q3 24 | — | $12.4M | ||
| Q2 24 | — | — |
| Q1 26 | $1.3B | — | ||
| Q4 25 | $1.3B | $1.1B | ||
| Q3 25 | $1.3B | $1.0B | ||
| Q2 25 | $1.3B | $995.6M | ||
| Q1 25 | $1.2B | $978.4M | ||
| Q4 24 | $1.1B | $958.2M | ||
| Q3 24 | $1.2B | $904.4M | ||
| Q2 24 | $1.1B | $352.5M |
| Q1 26 | $1.7B | — | ||
| Q4 25 | $1.7B | $1.3B | ||
| Q3 25 | $1.7B | $1.3B | ||
| Q2 25 | $1.7B | $1.2B | ||
| Q1 25 | $1.6B | $1.2B | ||
| Q4 24 | $1.6B | $1.2B | ||
| Q3 24 | $1.6B | $1.1B | ||
| Q2 24 | $1.6B | $1.0B |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.02× | ||
| Q3 25 | — | 0.02× | ||
| Q2 25 | — | 0.03× | ||
| Q1 25 | — | 0.02× | ||
| Q4 24 | — | 0.03× | ||
| Q3 24 | — | 0.01× | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $40.1M | $52.2M |
| Free Cash FlowOCF − Capex | $33.8M | — |
| FCF MarginFCF / Revenue | 12.5% | — |
| Capex IntensityCapex / Revenue | 2.3% | — |
| Cash ConversionOCF / Net Profit | 0.99× | 3.74× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $40.1M | — | ||
| Q4 25 | $67.3M | $52.2M | ||
| Q3 25 | $65.6M | $48.4M | ||
| Q2 25 | $47.3M | $59.2M | ||
| Q1 25 | $36.5M | $31.1M | ||
| Q4 24 | $52.3M | $36.3M | ||
| Q3 24 | $51.3M | $21.7M | ||
| Q2 24 | $45.0M | $22.8M |
| Q1 26 | $33.8M | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $16.6M |
| Q1 26 | 12.5% | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 12.7% |
| Q1 26 | 2.3% | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 4.7% |
| Q1 26 | 0.99× | — | ||
| Q4 25 | 1.72× | 3.74× | ||
| Q3 25 | 1.63× | 1.23× | ||
| Q2 25 | 1.23× | 3.86× | ||
| Q1 25 | 0.98× | 2.11× | ||
| Q4 24 | 1.56× | 1.14× | ||
| Q3 24 | 1.52× | 0.26× | ||
| Q2 24 | 1.40× | 2.39× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BCPC
Segment breakdown not available.
INVX
| Products | $202.7M | 74% |
| Leasing | $42.3M | 15% |
| Services | $28.6M | 10% |
